HOME › Research Insight › Thermofisher Scientific Inc. (Life Technologies) and Illumina Inc. Lead the Global Transcriptomics Market
Thermofisher Scientific Inc. (Life Technologies) and Illumina Inc. Lead the Global Transcriptomics Market
The global transcriptomics market is dominated by two major players, Thermofisher Scientific (Life Technologies) (U.S.) and Illumina Inc. (U.S.)accounting for more than 50% of the global market in 2013.
Thermofisher Scientific Inc. (Life Technologies) (U.S.) was a leading player in the transcriptomics market in 2013 with 30.2% share in the global market. The leading position of this company in this market was mainly attributed to its strong presence in the PCR and sequencing market. Over the years, the company has maintained its leading position through a strong distribution network across North America, Europe, Middle East and Africa, Asia-Pacific, and Latin America. Moreover, the company focuses on new product launches and acquisitions as its key business strategies, to ensure its growth in the global transcriptomics market. For instance, in 2014, Thermofisher acquired Life Technologies Corporation which has led to the enhancement of PCR product portfolio of the company.
Illumina Inc. (U.S.) was another prominent player in the global transcriptomics market with 21.5% share in 2013. The dominant position of this company is mainly attributed to its diverse product portfolio offering a various products for RNA sequencing. The major products offered by Illumina are for targeted RNA sequencing, mRNA sequencing, total RNA sequencing, small RNA sequencing, low-quality and FFPE RNA-Seq, ultra-low RNA input sequencing, ribosome profiling, and RNA-Seq data analysis, Moreover, the strong manufacturing and distribution channel of the company across the world, which enables it to serve customers in the Americas, Africa, Europe, Middle East, and Asia-Pacific region.
Apart from these two, Hoffmann-La Roche (Switzerland.) is also a prominent player in the transcriptomics market with extensive product portfolio for RNA analysis. Affymetrix Inc. (U.S.) and Agilent Technologies Inc. (U.S.) are the other prominent players in the microarray market. However, with the transition from microarrays to next generation sequencing the microarray businesses of these players have been adversely affected which has negatively impacted the market position of these players.
Some of the other players in this market are GE Healthcare (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.) and Fluidigm Corporation (U.S.).
RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019
North - Dominion Plaza,
Suite 800, Dallas, TX 75252